Vivo Cannabis Inc
TSX:VIVO
Vivo Cannabis Inc
TSX:VIVO
Price:
0.025
CAD
Market Closed
Market Cap:
CA$9.3m
Relative Value
There is not enough data to reliably calculate the relative value of VIVO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIVO
Relative Value
Base Case
Not Available
Multiples Across Competitors
VIVO Competitors Multiples
Vivo Cannabis Inc Competitors
Vivo Cannabis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Vivo Cannabis Inc
TSX:VIVO
|
9.3m CAD | 0.4 | -0.1 | -0.7 | -0.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.2B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF | 4.7 | 30.8 | 13 | 15.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.3B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF | 5.6 | 22.5 | 13.8 | 17.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.3B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
